Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 18 Source: CRO
- €4.2 billion turnover
-
€255.3 million
profit - 10,400 employees
-
31st Dec 17 Source: CRO
- €4.1 billion turnover
-
€229.2 million
profit - 10,400 employees
- 4 more years available »
Ranking
By Turnover
(€4.2 billion)- 28th in Top Companies
- 6th in Health
- 5th in Pharma
By Employees
(10,400)- 21st in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.2 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- Jun 25 Couple claim newly built home uninhabitable due to structural defects
- Jun 25 Lisburn-based company wins £10.5m contracts for ultra-luxury properties
- Jun 25 O’Brien-linked company granted planning permission for office block alteration
- Jun 25 O’Brien-linked company given permission for office block alteration
- Jun 25 Aircoach owner defeats investor attempt to oust board members